Clinical Trial Update: Safety of Reduced Infliximab Infusion Time [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the safety of a reduced infusion time for infliximab in inflammatory bowel diseases; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Infliximab (Remicade) (Infliximab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Inflammatory Bowel Diseases | Phase 4 | Status: COMPLETED | Results posted: 2024-08-29